Public Relations Management News - 2018

:  
2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 1992 | All

2 News Found

SpinalCyte Applies with FDA to Expand Human Clinical Trial of CybroCell™ Dermal Fibroblasts as Investigational New Drug (IND)

HOUSTON, April 12, 2018 - SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus …

  • Print
  • Group(s): actfnly
  • Released: April 12th, 2018 01:22 PM
  • Author: Daniel Keeney
  • Phone: (800) 596-8708
  • Email:
  • Website: http://www.spinalcyte.com/

Phase 1/2 Clinical Trial Results Positive for SpinalCyte’s CybroCell™ Dermal Fibroblasts

Landmark Human Trial Suggests Treatment Could Eliminate Need for Opioids in Some Patients HOUSTON – February 13, 2018 – Degenerative …

  • Print
  • Group(s): actfnly
  • Released: February 13th, 2018 12:59 PM
  • Author: Daniel Keeney
  • Phone: (800) 596-8708
  • Email:
  • Website: http://www.spinalcyte.com/